Trials / Completed
CompletedNCT02219529
Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases
Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases: A Prospective Self-controlled Comparative Multicenter Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 350 (actual)
- Sponsor
- Changhai Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
A new Magnetic-controlled Capsule Endoscopy (MCE) was developed by ANKON and got SFDA's approval in China in 2013. It has recently been evaluated to compare the diagnostic accuracy of MCE with that of standard gastroscopy for gastric diseases in 70 patients with encouraging results (In Press). To further testify the diagnostic accuracy of MCE for both the diffuse and focal diseases in stomach, we performed this single-blinded multi-center prospective study compared MCE with gastroscopy in patients with gastric symptoms and indication for upper GI Endoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MCE | |
| DEVICE | Standard gastroscopy |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2015-01-01
- Completion
- 2015-02-01
- First posted
- 2014-08-19
- Last updated
- 2015-07-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02219529. Inclusion in this directory is not an endorsement.